Pfizer CEO Bourla on R&D, Obesity Drugs, and Winning Back Investors

from At Barron's · host At Barron's

Pfizer Chief Executive Albert Bourla says recent Seagen acquisition provides "tremendous opportunity for growth." Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Jan 18, 2024

Embed this episode

Attribution link and audio player

What this episode covers

Pfizer Chief Executive Albert Bourla says recent Seagen acquisition provides "tremendous opportunity for growth."

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Pfizer CEO Bourla on R&D, Obesity Drugs, and Winning Back Investors

0:00 19:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of At Barron's?

This episode is 19 minutes long.

When was this At Barron's episode published?

This episode was published on January 18, 2024.

Can I download this At Barron's episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!